Disclaimer - Please note that the insurance accepted list may not be complete. Prior to scheduling an appointment, please contact the doctors' office to verify their participation in your plan.
Business Offices
Address
17 East 102 Street Floor 6th Floor Room West Tower
New York, NY 10029
Residency, Internal Medicine, Mount Sinai Hospital
Internship, Internal Medicine, Mount Sinai Hospital
Awards
2009 Team Award, Hospitalist Service Mount Sinai Hospital
2008 Healthcare Quality Award, Hospitalist Service Mount Sinai Department of Medicine
2001 House Staff Ambulatory Preceptor Award
Dr. Dunn received his medical degree at the New York
University School of Medicine. He performed his internship and residency at Mount SinaiMedicalCenter
and stayed on as faculty after completion. He is currently professor of
Medicine and Director of the Hospitalist Service in the Department of Medicine.
His research interests are in anticoagulation and thrombosis, most specifically
in venous thromboembolism, atrial fibrillation, and the perioperative
management of warfarin.Dr. Dunn has
collaborated and led national studies in this field, including a multicenter
North American study on the perioperative management of oral anticoagulation.
He lectures nationally on various topics in anticoagulation and has written
numerous journal articles, including perioperative bridging therapy, outpatient
treatment of deep vein thrombosis, and the prevention of venous thromboembolism
for medical inpatients.His work has
been published in the American Journal of
Medicine, Archives of Internal
Medicine, Journal of Thrombosis and
Thrombolysis, and Thrombosis and
Haemostasis.In addition, Dr. Dunn
is a co-author of the AmericanCollege of Chest
Physician’s guidelines on anticoagulation and thrombosis.Dr. Dunn is a Fellow of the AmericanCollege
of Physicians, a Fellow of the Society of Hospital Medicine, and a member of
the Society of General Internal Medicine and the International Society of
Thrombosis and Haemostasis.
Clinical Interests
Anticaogulation and Thrombosis
Outpatient Deep Vein Thrombosis Treatment
Mathematical Modelling of Warfarin Dose Adjustments
Clinical Programs
Director, The Mount Sinai Hospital Outpatient DVT Treatment Program
Director, Early Discharge on Warfarin Program
Community Acquired Pneumonia Clinical Pathways Project
Director, Primary Care Anticoagulation Service
Training
Education and Training
MD, New York University
Residency, Internal Medicine, Mount Sinai Hospital
Internship, Internal Medicine, Mount Sinai Hospital
Board Certification
Internal Medicine
Clinical Practice
Specialty
Internal Medicine
Clinical Interests
Atrial Fibrillation
Thrombosis
Patient Safety
Languages
English
Board Certification
Internal Medicine
Research
Anticoagulation and thrombosis, including prophylaxis and treatment of DVT and PE, and perioperative management of warfarin
Research Projects
Site Director, Peripheral Arterial Disease Detection Project (PAD PARTNERS) - Director for one of 15 sites in a multicenter trial of peripheral arterial disease screening.
Site Director, MATISSE DVT and PE trials. International randomized trials of DVT and PE treatment.
Principal Investigator - Outpatient DVT Treatment Using LMWH. Prospective cohort study of outpatient DVT treatment with LMWH.
Principal Investigator - Mathematical Modeling of Warfarin Dose. Derivation and validation of a model for warfarin dosage adjustments.
Principal Investigator - Effect of Warfarin Titration on Delay of Discharge.
Principal Investigator - The Use of Low-molecular-weight Heparin in the Perioperative Period for Patients on Long-term Warfarin.
Publications
Dunn A, Turpie AG G. Perioperative management of patients on oral anticoagulants: a systematic review.. Arch Intern Med. 2009; 163: 901-908.
Dunn A, Bioh D, Beran M, Capasso M, Siu A. The impact of intravenous heparin administration on duration of hospitalization. . Mayo Clinic Proc. 2004; 79: 159-163.
Dunn A, Ho W, Wisnivesky J, Moore C, McGinn T, Sacks HS. Perioperative management of patients on oral anticoagulants: a decision-analysis. . Medical Decision-Making. 2005; 25: 387-397.
Dunn AS, Kaboli K, Chan H, Hubert R, White RH. Do patients followed in anticoagulation clinics for antiphospholipid antibody syndrome meet criteria for the disorder? . Thromb Haem. 2005; 94: 548-554.
Dunn A, Brenner K, Halm E. The magnitude of an iatrogenic disorder: A systematic review of the incidence of venous thromboembolism for general medical inpatients . Thromb Haem. 2006; 95: 758-762.
Dunn A, Spyropoulos AC, Turpie AG G. Bridging therapy in patients on long-term oral anticoagulant therapy who require surgery: the Prospective Perioperative Enoxaparin Cohort Trial (PROSPECT).. J Thromb Haem. 2007; 5: 2211-2218.
Douketis JD, Berger PB, Dunn AS. The perioperative management of antithrombotic therapy. American College of Chest Physicians evidence-based practice guidelines (8th edition).. Chest 2008; 133: 299-339S.
Dunn A. . Hospital medicine in high-def: The importance of defining the local mission of hospitalist groups. . Mount Sinai J Med 2008; 75: 415-417.
Dunn A, Markoff B. Physician-physician communication: What’s the hang-up? . J Gen Intern Med 2009; 24: 437-439.
View All Service Areas
Discover how The Mount Sinai Medical Center can offer you the most advanced and compassionate inpatient and outpatient care.
Participating in Mount Sinai’s clinical trials allows you to take advantage of innovative treatments as we work together to advance the future of medicine.
